Refractory hypoglycemia from ciprofloxacin and glyburide interaction

Journal of Toxicology - Clinical Toxicology

Volumn 42, Issue 3, 2004, Pages 295-297

  Lin, George ^a   Hays, Daniel P ^a   Spillane, Linda ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Ciprofloxacin; Ciprofloxacin interaction; Glyburide; Glyburide interaction; Refractory hypoglycemia

Indexed keywords

CIPROFLOXACIN; GLIBENCLAMIDE; GLUCOSE; ORAL ANTIDIABETIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOOD GLUCOSE MONITORING; CASE REPORT; COMBINATION CHEMOTHERAPY; COMPLEX FORMATION; DIABETES MELLITUS; DRUG CROSS REACTIVITY; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INFECTION; MALE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

AGED; ANTI-INFECTIVE AGENTS; BLOOD GLUCOSE; CIPROFLOXACIN; DIABETES MELLITUS, TYPE 2; DIET; DRUG INTERACTIONS; GLUCOSE; GLYBURIDE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAVENOUS; MALE; URINARY TRACT INFECTIONS;

EID: 4444256835     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-120037431     Document Type: Article

References (10)

1. Hogan DB. Revisiting the O complex: urinary incontinence, delirium and polypharmacy in elderly patients. Can Med Assoc J 1997; 157(8):1071-1077.
2. Chung MK, Bartfield JM. Knowledge of prescription medications among elderly emergency department patients. Ann Emerg Med 2002; 39(6).
3. Baker SE, Hangii MC. Possible gatifloxacin-induced hypoglycemia. Ann Pharmacother 2002; 36(11):1722-1726.
4. Menzies DJ, Dorsainvil PA, Cunha BA, Johnson DH. Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents. Am J Med 2002; 113(3):232-234.
5. Roberge RJ, Kaplan R, Frank R, Fore C. Glyburide-Ciprofloxacin interaction with resistant hypoglycemia. Ann Emerg Med 2000; 36(2):160-163.
6. Ciprofloxacin. West Haven, Connecticut: Bayer Pharmaceuticals, 2000. [package insert].
7. Kim K, Park JY. Inhibitory effect of glyburide on cytochrome P450 isoforms in human liver microsomes. Drug Metab Dispos 2003; 31(9):1090-1092.
8. Michalets EL. Update: clinically significant cytochrome P-450 drug interactions. Pharmacotherapy 1998; 18(1):84-112.
9. Kirchheiner J, Brockmoller J, Meineke I, Bauer S, Rohde W, Meisel C, Roots I. Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers. Clin Pharmacol Ther Apr. 2002; 71(4):286-296.
10. Maeda N, Tamagawa T, Niki I, Miura H, Ozawa K, Watanabe G, Nonogaki K, Uemura K, Iguchi A. Increase in insulin release from rat pancreatic islets by quinolone antibiotics. Br J Pharmacol 1996; 117:372-376.